[1] Loeser RF, Goldring SR, Scanzello CR, et al. Osteoarthritis: a disease of the joint as an organ[J]. Arthritis Rheum, 2012, 64(6):1697-1707.
[2] Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification[J]. Genes Dev, 1998, 12(9):1260-1268.
[3] KwanTatS, Amiable N, Pelletier JP, et al. Modulation of OPG,RANK and RANKL by human chondrocytes and their implication during osteoarthritis[J]. Rheumatology, 2009, 48(12):1482-90.
[4] 莫紫贺, 黄江鸿, 王大平, 等. 软骨组织工程相关细胞因子研究新进展[J]. 骨科, 2015, 6(3):165-168.
[5] Yuan XL, Meng HY, Wang YC, et al. Bone-cartilage interface crosstalk in osteoarthritis: potential pathways and future therapeutic strategies[J]. Osteoarthritis Cartilage, 2014, 22(8):1077-1089.
[6] Aigner T, Haag, J, Martin J, et al. Osteoarthritis: aging of matrix and cells - going for a remedy[J]. Curr Drug Targets, 2007,8(2):325-331.
[7] Baud'huin M, Duplomb L, Teletchea S, et al. Osteoprotegerin: multiple partners for multiple functions[J]. Cytokine Growth Factor Rev, 2013, 24(5):401-409.
[8] Wang B, Jin H, Shu B, et al. Chondrocytes-specific expression of osteoprotegerin modulates osteoclast formation in metaphyseal bone[J]. Sci Rep, 2015, 5:13667.
[9] Shimizu S, Asou Y, Itoh S, et al. Prevention of cartilage destruction with intraarticular osteoclastogenesis inhibitory factor/osteoprotegerin in a murine model of osteoarthritis[J]. Arthritis Rheum, 2007, 56(10):3358-3365.
[10] Sagar DR, Ashraf S, Xu L, et al. Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis[J]. Ann Rheum Dis, 2014, 73(8):1558-1565.
[11] 何影, 李松. 髁突软骨与生长板软骨在发育中差异研究进展[J]. 中国实用口腔科杂志, 2009, 2(8):498-501.
[12] Carda C, Silvestrini G, Gomez de Ferraris ME, et al. Osteoprotegerin (OPG) and RANKL expression and distribution in developing human craniomandibular joint[J]. Tissue Cell, 2005, 37(3):247-255.
[13] Wakita T, Mogi M, Kurita K, et al. Increase in RANKL:OPG ratio in synovia of patients with temporomandibular joint disorder[J]. J Dent Res, 2006, 85(7):627-632.
[14] Liu YD, Yang HX, Liao LF, et al. Systemic administration of strontium or NBD peptide ameliorates early stage cartilage degradation of mouse mandibular condyles[J]. Osteoarthritis Cartilage, 2016, 24(1):178-187.
[15] Liu YD, Liao LF, Zhang HY, et al. Reducing dietary loading decreases mouse temporomandibular joint degradation induced by anterior crossbite prosthesis[J]. Osteoarthritis Cartilage, 2014, 22(2):302-312. |